The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
The second-generation antipsychotic olanzapine is effective in reducing psychotic symptoms but can cause extreme weight gain in human patients. We investigated the role of the gut microbiota in this adverse drug effect using a mouse model. First, we used germ-free C57BL/6J mice to demonstrate that gut bacteria are necessary and sufficient for weight gain caused by oral delivery of olanzapine. Second, we surveyed fecal microbiota before, during, and after treatment and found that olanzapine potentiated a shift towards an "obesogenic" bacterial profile. Finally, we demonstrated that olanzapine has antimicrobial activity in vitro against resident enteric bacterial strains. These results collectively provide strong evidence for a mechanism underlying olanzapine-induced weight gain in mouse and a hypothesis for clinical translation in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Effect of high-fat diet (HFD) and olanzapine (OLZ) treatment on diversity of gut microbiota during crossover study. (A) Within-subject (α) diversity, quantified by Fisher's α [45]; larger values indicate greater diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Panels are split by study arm (see Error! Reference source not found.) and points are colored according to diet and treatment status: on regular chow prior to initiation of HFD (regular), during treatment with placebo (HFD-placebo) or during treatment with OLZ (HFD-OLZ). Each point represents a single individual and bars indicate 95% confidence intervals about the point estimates; observations on the same subject are connected by a grey line. (B) Between-subjects (β) diversity (n = 95 samples = 4 time points ×24 subjects – 1 failed sample). Pairwise distances between samples were calculated using weighted UniFrac and visualized using non-metric multidimensional scaling along two axes, which together explain 98% of between-subjects variance. Observations on the same subject are connected by a grey line.](https://figures.cochat.ai/paper-figures/a936ae05344f4303a8dbe754682036f6/the-antipsychotic-olanzapine-interacts-with-the-gut-microbiome-to-cause-weight-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Olanzapine administration decreased overall microbial diversity, lowered abundance of Bacteroidia, and increased abundances of Erysipelotrichia, Actinobacteria, and Gammaproteobacteria.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“a lack of significant increase of the body weight in olanzapine-treated GF mice and a rapid weight gain upon microbial colonization in this study indicate that the olanzapine-induced weight gain was dependent on the presence of gut microbiota [188].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [188]
In the citing paper
“olanzapine, which induces alterations in gut microbiome composition in rodents linked to the weight gain and other metabolic side effects that are associated with its use”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Morgan et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“0 package [38].”
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885 · cited 1×
“OTUs were assigned a taxonomic identity with the RDP classifier [37] trained on the most recent release (4 February 2011) of the Los Alamos National Laboratory’s GreenGenes taxonomic reference (gg_97_otus_4feb2011), using the scripts in the QIIME v1.”
MethodA new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828 · cited 2×
“Between-group differences in overall microbiota composition were assessed by PERMANOVA [42] as implemented in the R package vegan (http://vegan.r-forge.r-project.org), and visualized using nonmetric multidimensional scaling as implemented in the R package MASS [43].”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Recent studies in animal models and humans have demonstrated a causal role for the gut microbiome in obesity [19–24], which is mediated by complex interactions with host environment [25, 26], diet [21, 27] and genetics [25, 28].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“Bacterial concentrations can be as high as 10(11) cells/mL in the distal gut, encompassing a gene repertoire 150 times larger than that of the human host [15] with broad-ranging metabolic capacity [16, 17].”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“The specific alterations in gut community composition that we attribute to olanzapine are similar to those attributed to high-fat diet [19, 21, 22, 30, 31].”
BackgroundUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227 · cited 8×
“In the weighted UniFrac analysis (Fig.”
MethodInfluentialEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · cited 1×
“Since their introduction in the 1990s, olanzapine and other atypical antipsychotics have come into widespread clinical use because they are efficacious and usually lack the extrapyramidal adverse drug reactions associated with older, ‘‘typical’’ antipsychotics like haloperidol [1, 2].”
BackgroundFastTree: Computing Large Minimum Evolution Trees with Profiles instead of a Distance Matrix
Price, M. N., Dehal, P. S., & Arkin, A. P. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp077 · Cited by 5,602 · cited 1×
“Consensus sequences for the OTUs were aligned using PyNAST [39] (via QIIME) guided by the aforementioned GreenGenes reference alignment, and a corresponding phylogeny inferred using FastTree [40] (via QIIME).”
Method
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
“This raises the possibility that direct bacterial inhibition may not only manifest as side effect for antipsychotics 26, but also be part of their MoA.”
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Physiology · doi:10.1113/jp273106 · Cited by 813
“Indeed, recent studies from our group (Davey et al. 2012; 2013) and others (Morgan et al. 2014; Bahr et al. 2015) point to a key role of the microbiome in manifesting antipsychotic-induced weight gain.”
BackgroundSystematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597
Metadata
- Authors
- Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., Kawula, T. H., Bower, M. A., Sartor, R. B., & Sullivan, P. F.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Jackson Laboratory (US)
- Corresponding author
- Sullivan, Patrick F.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-15
- Volume
- 9
- Issue
- 12
- Pages
- e115225
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4266663
- OpenAlex
- W2072944905
- Cited by
- 197
- References
- 61
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 19 · 2023: 25 · 2022: 21 · 2021: 17 · 2020: 22 · 2019: 23 · 2018: 16 · 2017: 9 · 2016: 7 · 2015: 6
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- UNC Libraries
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (P40OD010995)
- National Institute of Mental Health (R21MH097173, K01MH094406, F30MH103925)
- National Institute of General Medical Sciences (T32GM008719, T32GM067553)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034987, P30DK056350)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- olanzapine, gut microbiota, weight gain, antipsychotic adverse effects, germ-free mice, antimicrobial activity, atypical antipsychotics, drug-microbiome interactions
- MeSH terms
- Gastrointestinal Microbiome, Olanzapine, Animals, Benzodiazepines, Female, Antipsychotic Agents, Weight Gain, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse. https://app.cochat.ai/papers/10.1371/journal.pone.0115225
- The paper
- Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., Kawula, T. H., Bower, M. A., Sartor, R. B., & Sullivan, P. F. (2014). The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse. PLoS ONE. https://doi.org/10.1371/journal.pone.0115225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.